Abstract
The use of adenoviral vectors as potent gene delivery systems requires expression of the Coxsackievirus/adenovirus receptor (CVADR) on the target cell surface. This receptor is important for virus attachment to the cell surface. For effective internalization of the vector into the target cell the integrins αvβ3 and/or αvβ5 are needed. Since there have been reports of loss of CVADR in bladder cancer cell lines, we wanted to investigate the expression of this receptor in bladder carcinoma biopsies. Surgical biopsies, as well as five human bladder cancer cell lines, were analyzed for expression of CVADR, the integrins αvβ3 and αvβ5 and MHC class I. Further, we studied the ability to transduce these cell lines using adenoviral vectors. Immunohistochemistry revealed that all biopsies (27/27) were positive for CVADR. Some variation in expression was evident, and superficially growing tumors stained more strongly than invasive ones. Most human tumors expressed the integrin αvβ5 (14/24), whereas integrin αvβ3 was less frequently seen (3/20). The established cell lines were efficiently transduced with adenoviral vectors, and transduction could be reduced with anti-CVADR antibodies. The abundance of appropriate viral receptors on tumor biopsy cells is a further argument for using adenoviral vectors in gene therapy of bladder cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brenner M . Gene transfer by adenovectors Blood 1999 12: 3965–3967
Roelvink PW et al. The Coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E and F J Virol 1998 10: 7909–7915
Tomko RP, Xu R, Philipson L . HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses Proc Natl Acad Sci USA 1997 94: 3352–3356
Fechner H et al. Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barrier Gene Therapy 1999 6: 1520–1535
Tomko RP et al. Expression of the adenovirus receptor and its interaction with the fiber knob Exp Cell Res 2000 255: 47–55
Bergelson JM . Receptors mediating adenovirus attachment and internalisation Biochem Pharm 1999 57: 975–979
Wickham TJ, Mathias P, Cheresh DA, Nemerow GR . Integrins αvβ3 and αvβ5 promote adenovirus internalisation but not virus attachment Cell 1993 1993: 73
Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR . Integrin αvβ5 selectively promotes adenovirus mediated cell membrane permeabilization J Cell Biol 1994 127: 257–264
Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G . Heparan sulfate glycoaminoglycans are involved in adenovirus type 5 and 2-host cell interactions Virol 2000 268: 382–390
Bergelson JM . Isolation of a common receptor for Coxsackie B viruses and denoviruses 2 and 5 Science 1997 275: 1320–1323
Parsons CL, Shrom SH, Hanno PM, Mulholland SG . Bladder surface mucin-examination of possible mechanisms for its antibacterial effect Invest Urol 1978 16: 196–200
Engler H et al. Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents Urology 1999 53: 1049–1052
McDonalds D et al. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells Gene Therapy 1999 6: 1512–1519
Li Y et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy Cancer Res 1999 59: 325–330
Loskog A et al. Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer J Urol 2001 166: 1093–1097
Brooks PC, Clark RAF, Cheresh DA . Requirement of vascular integrin αvβ3 for angiogenesis Science 1994 22: 569–571
Carson SD, Hobbs JT, Tracy SM, Chapman NM . Expression of the Coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density J Virol 1999 8: 7077–7079
Werthman PE et al. Adenoviral–p53 gene transfer to orthotopic and peritoneal murine bladder cancer J Urol 1996 155: 753–756
Hsu K-HL, Lonberg-Holm K, Alstein B, Crowell RL . A monoclonal antibody specific for the cellular receptor for the group B Coxsackieviruses J Virol 1988 5: 1647–1652
Acknowledgements
This study was supported by The Swedish Cancer Society, The Swedish Gene Therapy Program and the Lions’ Cancer Fund at Uppsala University Hospital. The authors thank Dr Frank Graham, McMaster University for providing the Ad-dl70-3 vector, and Professor Jörgen Carlsson, Uppsala University and PhD Agneta Richter-Dahlfors, Karolinska Institute, for providing the cell lines, respectively.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loskog, A., Hedlund, T., Wester, K. et al. Human urinary bladder carcinomas express adenovirus attachment and internalization receptors. Gene Ther 9, 547–553 (2002). https://doi.org/10.1038/sj.gt.3301689
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301689
Keywords
This article is cited by
-
Molecular targets and targeted therapies in bladder cancer management
World Journal of Urology (2009)
-
Immunotherapy for superficial bladder cancer
Cancer Immunology, Immunotherapy (2005)
-
Expression and significance of coxsackie and adenovirus receptor in renal-cell carcinoma
Chinese Journal of Clinical Oncology (2005)
-
Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo
Gene Therapy (2003)